Naokuni Uike

9.0k citations

151 papers · 5.1k indexed · 2 hit papers · h-index 37

Impact in

Immunology top 0.5%
- T-cell and Retrovirus Studies
- Immune Cell Function and Interaction
Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment

Papers in

Hematology 42
- Acute Myeloid Leukemia Research 16
Genetics 33
- Chronic Lymphocytic Leukemia Research 28

Co-authors: Kensei Tobinai Atae Utsunomiya Michinori Ogura Masao Tomonaga Takashi Ishida Toshihiro Miyamoto Kunihiro Tsukasaki Ryuzo Ueda
Journals: Blood (23 papers)International Journal of Hematology (14 papers)British Journal of Haematology (8 papers)Journal of Clinical Oncology (7 papers)Cancer Science (7 papers)
Partner nations: Japan United States Greece

In The Last Decade

Naokuni Uike

149 papers receiving 5.0k citations

Hit Papers

align trajectories log scale

Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma 2015 · 367 citations

Peers

Countries citing papers authored by Naokuni Uike

Since Specialization

Citations

This map shows the geographic impact of Naokuni Uike's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naokuni Uike with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naokuni Uike more than expected).

Fields of papers citing papers by Naokuni Uike

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naokuni Uike. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naokuni Uike. The network helps show where Naokuni Uike may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Naokuni Uike, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Naokuni Uike Line = papers co-authored together Naokuni Uike links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prognosis of patients with adult T‐cell leukemia/lymphoma in Japan: A nationwide hospital‐based study Cancer Science ·Yoshitaka Imaizumi, Masako Iwanaga, Kisato Nosaka, Kenji Ishitsuka, Kenichi Ishizawa, Shigeki Ito, Masahiro Amano, Takashi Ishida, Naokuni Uike, Atae Utsunomiya, Koichi Ohshima, Junji Tanaka, Y. Tokura, Kensei Tobinai, Toshiki Watanabe, Kaoru Uchimaru, Kunihiro Tsukasaki, (unknown)	2020	48
2	Carfilzomib monotherapy in Japanese patients with relapsed or refractory multiple myeloma: A phase 1/2 study Cancer Science ·Shinsuke Iida, Takashi Watanabe, Morio Matsumoto, Kenshi Suzuki, Kazutaka Sunami, Tadao Ishida, Kiyoshi Ando, Takaaki Chou, Shuji Ozaki, Masafumi Taniwaki, Naokuni Uike, Hirohiko Shibayama, Kiyohiko Hatake, Koji Izutsu, Takayuki Ishikawa, 丁烨 Ding Ye, Kensei Tobinai	2019	6
3	The outcome and characteristics of patients with relapsed adult T cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation Hematological Oncology ·Koji Kato, Naokuni Uike, Atsushi Wake, Makoto Yoshimitsu, Anna Sendt, Yasushi Sawayama, Y Takatsuka, Takahiro Fukuda, Naoyuki Uchida, Tetsuya Eto, Yasuhiro Nakashima, Tadakazu Kondo, Jun Taguchi, Toshihiro Miyamoto, Hirohisa Nakamae, Tatsuo Ichinohe, Ritsuro Suzuki, Atae Utsunomiya, (unknown)	2018	15
4	Efficacy of upfront high-dose chemotherapy plus rituximab followed by autologous peripheral blood stem cell transplantation for untreated high-intermediate-, and high-risk diffuse large B-cell lymphoma: a multicenter prospective phase II study (JSCT-NHL04) International Journal of Hematology ·Tohru Murayama, Takahiro Fukuda, Hirokazu Okumura, Kazutaka Sunami, Marko Šarlija, Yoshinobu Maeda, Hisashi Tsurumi, Naokuni Uike, Tomonori Hidaka, Y Takatsuka, Tetsuya Eto, Hiroyuki Tsuda, Tomoaki Fujisaki, Toshihiro Miyamoto, Naoko Tsuneyoshi, Satoshi Iyama, Koji Nagafuji, Mine Harada	2016	7
5	Molecular Characterization of Chronic-type Adult T-cell Leukemia/Lymphoma Cancer Research ·Noriaki Yoshida, Kennosuke Karube, Atae Utsunomiya, Kunihiro Tsukasaki, Yoshitaka Imaizumi, Naoya Taira, Naokuni Uike, Jingmin Chi, Kotaro Arita, Miyuki Suguro, Shinobu Tsuzuki, Tomohiro Kinoshita, Koichi Ohshima, Masao Seto	2014	34
6	Does tumoral 111In-ibritumomab accumulation correlate with therapeutic effect and outcome in relapsed or refractory low-grade B-cell lymphoma patients undergoing 90Y-ibritumomab radioimmunotherapy? European Radiology ·Koichiro Kaneko, Ilseung Choi, Makoto Nakagawa, K. Shinozaki, Naokuni Uike	2014	4
7	Low incidences of acute and chronic graft-versus-host disease after unrelated bone marrow transplantation with low-dose anti-T lymphocyte globulin International Journal of Hematology ·Kazuo Hatanaka, Shigeo Fuji, Kazuhiro Ikegame, Ruri Kato, Atsushi Wake, Michihiro Hidaka, Toshiro Ito, Masami Inoue, Yoshihisa Nagatoshi, Akiyoshi Takami, Naokuni Uike, Hisashi Sakamaki, Hiromasa Yabe, Yasuo Morishima, Ritsuro Suzuki, Yoshiko Atsuta, Takahiro Fukuda	2012	9
8	Phase II/III Study of R-CHOP-21 Versus R-CHOP-14 for Untreated Indolent B-Cell Non-Hodgkin's Lymphoma: JCOG 0203 Trial Journal of Clinical Oncology ·Takashi Watanabe, Kensei Tobinai, Taro Shibata, Kunihiro Tsukasaki, Yasuo Morishima, Nobuo Maseki, Tomohiro Kinoshita, Takayo Suzuki, Motoko Yamaguchi, Kiyoshi Ando, Michinori Ogura, Masafumi Taniwaki, Naokuni Uike, Kengo Takeuchi, Shigeru Nawano, Takashi Terauchi, Tomomitsu Hotta	2011	45
9	Multicenter phase II study of bendamustine for relapsed or refractory indolent B‐cell non‐Hodgkin lymphoma and mantle cell lymphoma Cancer Science ·Ken Ohmachi, Kiyoshi Ando, Michinori Ogura, Toshiki Uchida, Kuniaki Itoh, Nobuko Kubota, Kenichi Ishizawa, Joji Yamamoto, Takashi Watanabe, Naokuni Uike, Ilseung Choi, Yasuhito Terui, Kensuke Usuki, Hirokazu Nagai, Nobuhiko Uoshima, Kensei Tobinai, (unknown)	2010	50
10	Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab Annals of Oncology ·Ritsuko Seki, Koichi Ohshima, Tomoaki Fujisaki, Naokuni Uike, Fumio Kawano, Hisashi Gondo, Shigeyoshi Makino, Tetsuya Eto, Yukiyoshi Moriuchi, Fumihiro Taguchi, T. Kamimura, Hiroyuki Tsuda, Kazuya Shimoda, Takashi Okamura	2009	25
11	The International Prognostic Index predicts outcome in aggressive adult T-cell leukemia/lymphoma: analysis of 126 patients from the International Peripheral T-cell Lymphoma Project Annals of Oncology ·Junji Suzumiya, K Ohshima, Kazuo Tamura, Kennosuke Karube, Naokuni Uike, Kensei Tobinai, Randy D. Gascoyne, Julie M. Vose, Jamés O. Armitage, Dennis D. Weisenburger	2009	41
12	Diagnosis and Treatment of Malignant Lymphoma Nihon Naika Gakkai Zasshi ·Kensei Tobinai, Junichi Kameoka, Naokuni Uike, Atsushi Shinagawa, Morihito Takita	2008	1
13	Remission induction therapy containing rituximab markedly improved the outcome of untreated mature B cell lymphoma British Journal of Haematology ·Hirokazu Nagai, Takahiro Yano, Tomoyuki Watanabe, Naokuni Uike, Seiichi Okamura, Shuichi Hanada, Fumio Kawano, Kazutaka Sunami, Yury Lukyanchuk, Morio Sawamura, Tetsuo Nishiura, Tomomitsu Hotta, Keizo Horibe	2008	7
14	Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced-Intensity Conditioning for Adult T Cell Leukemia/Lymphoma: Impact of Antithymocyte Globulin on Clinical Outcome Biology of Blood and Marrow Transplantation ·Ryuji Tanosaki, Naokuni Uike, Atae Utsunomiya, Yoshio Saburi, Masato Masuda, Masao Tomonaga, Tetsuya Eto, Michihiro Hidaka, Mine Harada, Ilseung Choi, Takeharu Yamanaka, Mari Kannagi, Masao Matsuoka, Jun Okamura	2008	43
15	Durable Response but Prolonged Cytopenia after Cladribine Treatment in Relapsed Patients with Indolent non-Hodgkin's Lymphomas: Results of a Japanese Phase II Study International Journal of Hematology ·Michinori Ogura, Yasuo Morishima, Yukio Kobayashi, Naokuni Uike, Susumu Sugai, Takaaki Chou, Masaharu Kasai, Ikuo Miura, Tohru Murayama, Yoshihiro Matsuno, Shigeo Nakamura, Shigeo Mori, Yasuo Ohashi, Kensei Tobinai, Anuradha Nair	2004	34
16	Randomized phase II study of biweekly CHOP anddose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin’s lymphoma: Japan Clinical Oncology Group Study 9505 Annals of Oncology ·Kuniaki Itoh, T. Ohtsu, Haruhiko Fukuda, Yusuke Sasaki, Michinori Ogura, Y Morishima, Ting‐Chao Chou, Kohsuke Aikawa, Naokuni Uike, 董川, Tatsuharu Ohno, Shu‐ichi Ikeda, 谢嗣极, Masafumi Taniwaki, Ibone Garcia-Borreguero, Miyuki Niimi, T Hotta, M Shimoyama, Kensei Tobinai	2002	44
17	Cefepime or carbapenem treatment for febrile neutropenia as a single agent is as effective as a combination of 4^th‐generation cephalosporin + aminoglycosides: Comparative study American Journal of Hematology ·Kazuo Tamura, Susan M.D. Rosenthal, Junichi Tsukada, M Masuda, Shu‐ichi Ikeda, W Strzalkowska, Fumio Kawano, Yoko Izumi, Naokuni Uike, Atae Utsunomiya, Yoshio Saburi, T Shibuya, Yoshifumi Imamura, Christos Lampoudis, S Okamura, Yang Chang-lin	2002	39
18	Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study Annals of Oncology ·Tomofumi Igarashi, Yukio Kobayashi, Michinori Ogura, T. Kinoshita, T. Ohtsu, Yosuke Sasaki, Y Morishima, Takashi Murate, M Kasai, Naokuni Uike, Masafumi Taniwaki, Yasuhiko Kano, Kazunori Ohnishi, Yoshihiro Matsuno, Shigeo Nakamura, Shigeki Mori, Yasuo Ohashi, Kensei Tobinai	2002	102
19	Morphological spectrum of cyclin D1‐positive mantle cell lymphoma: Study of 168 cases Pathology International ·Yasushi Yatabe, Ritsuro Suzuki, Yoshihiro Matsuno, K.A. Shen, Jennifer K. Cann, Jun‐ichi Tamaru, Yoshikazu Mizoguchi, Yuko Hashimoto, Motoko Yamaguchi, Masaru Kojima, Naokuni Uike, Masataka Okamoto, Jaillier Castrillón Catherine, Koichi Ichimura, Yasuo Morishima, Masao Seto, Taizan Suchi, Shigeo Nakamura	2001	35
20	[A comparative study of imipenem/cilastatin sodium BID vs QID in the treatment of infections associated with hematopoietic disorders]. PubMed ·Yoshinori Sawae, Yoshiyuki Niho, Takashi Okamura, Masahiro Murakawa, Takanori Teshima, Tomoaki Fujisaki, Kentaro Ikeda, Mitsuo Kozuru, Naokuni Uike, Makoto Katsuno	1994	1

About Naokuni Uike

Naokuni Uike is a scholar working on Hematology, Genetics, Immunology, Pathology and Forensic Medicine and Agronomy and Crop Science, having authored 151 papers that have together received 5.1k indexed citations. Recurring topics across this work include T-cell and Retrovirus Studies (50 papers), Lymphoma Diagnosis and Treatment (46 papers), Vector-Borne Animal Diseases (33 papers), Chronic Lymphocytic Leukemia Research (28 papers), Animal Disease Management and Epidemiology (23 papers), Viral-associated cancers and disorders (21 papers), Acute Myeloid Leukemia Research (16 papers) and Cutaneous lymphoproliferative disorders research (13 papers). The work is most often cited by research in Immunology (2.5k citations), Pathology and Forensic Medicine (1.8k citations), Genetics (852 citations), Agronomy and Crop Science (807 citations) and Hematology (772 citations). Naokuni Uike has collaborated with scholars based in Japan, United States and Greece. Frequent co-authors include Kensei Tobinai, Atae Utsunomiya, Michinori Ogura, Masao Tomonaga, Takashi Ishida, Toshihiro Miyamoto, Kunihiro Tsukasaki, Ryuzo Ueda, Koichi Akashi and Koichi Ohshima. Their work appears in journals such as Blood, International Journal of Hematology, British Journal of Haematology, Journal of Clinical Oncology and Cancer Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact